23-05-2013

The global life science entrepreneur, Dr David U’Prichard, will take on the role at the £20m Innovation Centre. The centre, developed by Health Science Scotland (HSS) and industry, brings together experts from academia, industry and the NHS to rapidly develop safer, more effective therapies ...

more

The need for OEMs to keep up with rapid technical advancements boosts outsourcing opportunities for electronics manufacturing service providers

22-05-2013

Original equipment manufacturers (OEMs) are increasingly turning to electronics manufacturing service (EMS) providers to better handle the escalating volumes of electronic content in the medical industry. With opportunities for high-level product assembly and complete build projects expected ...

more

22-05-2013

Malvern Instruments has announced an agreement with Proveris Scientific Corporation to provide a complete solution for nasal spray characterization. This solution comprises the SoloTM for Spraytec system (Proveris), a patented automated actuator and software for the control of the actuation ...

more

Having too much body fat makes arteries become stiff after middle age, a new study has revealed

16-05-2013

In young people, blood vessels appear to be able to compensate for the effects of obesity. But after middle age, this adaptability is lost, and arteries become progressively stiffer as body fat rises – potentially increasing the risk of dying from cardiovascular disease. The researchers ...

more

The increasing popularity of retrofit systems fuels market growth

15-05-2013

The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems. The emergence of retrofit systems based on flat panel technology has popularised DR systems, and will ...

more

13-05-2013

Injection of human stem cells into mice with tumors slowed down tumor growth, finds research published in BioMed Central's open access journal Stem Cell Research & Therapy. Human mesenchymal stem cells (MSC), isolated from bone marrow, caused changes in blood vessels supplying the tumor, and ...

more

Sustained revenue generation will depend on designing customised, user-friendly, integrated offerings

08-05-2013

The European market for interventional radiology and cardiology is heading towards maturity, especially in Western Europe. Although the economic slowdown and fewer orders had a negative impact on revenues in 2012, it is expected that expanding applications of interventional systems and the ...

more

08-05-2013

The trend towards automated high content assays, particularly for systems biology and drug discovery, has stimulated the development of automated fluorescence microscopy systems to image sample arrays. Today’s commercially available high content analysis (HCA) instruments predominantly employ ...

more

Re-shaping a regulatory agency fit for the future

07-05-2013

The first details of the planned reorganisation of the European Medicines Agency (EMA) have been announced. Rooted firmly in the Agency’s overall public and animal health mission, the changes reflect a renewed focus on three key elements: how to better support the scientific work of the EMA ...

more

06-05-2013

The European Medicines Agency (EMA) has been ordered by the General Court of the European Union not to provide documents as part of two access-to-documents requests until a final ruling is given by the Court. These interim rulings were made as part of court cases brought by two pharmaceutical ...

more